Biologiczna aktywność srebra i jego zastosowanie w medycynie

• Authors: Gabriela Bugla-Płoskońska , Anna Leszkiewicz

Title variants

EN

Biological activity of silver and its medical application

• Languages of publication: PL EN

Abstracts

EN

Silver has been known from their bactericidal property since the ancient time. Silver preparations in medicine were used for treatment of burns, as bandage for trauma and diabetic wounds, as silver-coated catheters, and in medical devices. This metal has been shown able to kill over 650 disease-causing bacteria, viruses, fungi and parasites. Silver is toxic to pathogen cells because it interferes with metabolic enzymes and DNA replication. The broad usage of silver is due both to its high bactericidal activity and low toxicity to the human organism.

• Journal: Kosmos
• Year: 2007
• Volume: 56
• Issue: 1-2
• Pages: 115-122

Dates

published

2007

Contributors

author

Gabriela Bugla-Płoskońska

• Zakład Mikrobiologii, Instytut Genetyki i Mikrobiologii, Uniwersytet Wrocławski, Przybyszewskiego 63/77, 51-124 Wrocław, Polska

author

Anna Leszkiewicz

• Zakład Mikrobiologii, Instytut Genetyki i Mikrobiologii, Uniwersytet Wrocławski, Przybyszewskiego 63/77, 51-124 Wrocław, Polska

References

• Atiyeh B. S., Costagliola M., Hayek S. N., Dibo S. A., 2007. Effect of silver on burn wound infection control and healing: Review of the literature. Burns 33, 139-148.
• Bosetti M., Masse A., Tobin E., Cannas M., 2002. Silver coated materials for external fixation devices; in vitro biocompatibility and genotoxicity. Biomaterials 23, 887-892.
• Brett D. W., 2006. A discussion of silver as an antimicrobial agent: alleviating the confusion. Ostomy Wound Manage. 52, 34-41.
• Brinker C. J., Scherer G. W., 1990. Sol-Gel Science. London.Academic Press, INC.
• Chmielowski J., Kłapcińska B., 1984. Mechanizmy pobierania metali przez drobnoustroje. Postępy Mikrobiol. 23, 63-88.
• Covington L. G., 2006. Engineering out the risk of infection with urinary catheters. Infection Control Resource 3, 200-211.
• Davenport K., Keeley F. X., 2005. Evidence for the use of silver-alloy-coated urethral catheters. J. Hosp. Infec. 60, 298-303.
• Dibrov P., Dzioba J., Gosink K. k., Höse C. C., 2002. Chemiosmotic mechanizm of antimicrobial activity of Ag+ in Vibrio cholerae. Antimicrob. Agents Chemiother. 8, 2668-2670.
• Ehrlich H. L., 1997. Microbes and metals. Appl. Microbiol. Biotechnol. 48, 687-692.
• Ennever F. K., 1994. Metals. Principles and Methods of Toxycology. Raven Press New York, Wyd. III, 12, 417-446.
• Gupta A., Matsui K., Lo J. F., Silver S., 1999. Molecular basis for resistance to silver cations in Salmonella. Nature Med. 5, 183-188.
• Hamilton-Miller J. M. T., Shah S., 1996. A microbiological assessment of silver fusidate, a novel topical antimicrobial agent. Int. J. Antimicrob. Agents 7, 97-99.
• Janiec W., 2001. Kompendium farmakologii. Wydawnictwo Lekarskie PZWL, Warszawa
• Jasiorski M., 2003. Synteza i spektroskopowe właściwości szkieł kwarcowych aktywowanych molekułami organicznymi i nieorganicznymi, otrzymywanych metodą zol-żel. Rozprawa doktorska. Zakład Spektroskopii Stanów Wzbudzonych INTiBS PAN.
• Jasiorski M., Maruszewski K., Stręk W., 2002. Optical behaviour of sol-gel derived photonic structures formed by submicron silica spheres. Mater. Sci. 20, 51-56.
• Kabata-Pendias A., Pendias H., 1993. Biogeochemia pierwiastków śladowych. Wydawnictwo Naukowe PWN, Warszawa.
• Kaźmierski M., Puchała J., Chrapusta-Klimeczek A., Mańkowski P., Jankowski A. 2005. Ocena skuteczności opatrunku typu hydrowłóknistego z dodatkiem srebra jonowego AQUACEL Ag® w miejscowym leczeniu oparzeń. Klinika Zakażeń 2, 108-113.
• Klasen H. J., 2000a. Historical review of the use of silver in the treatment of burns. Early uses. Burns 26, 117-130.
• Klasen H. J., 2000b. Historical review of the use of silver in the treatment of burns. Renewed interest for silver. Burns 26, 130-138.
• Li X. Z, Nikaido H., Williams K. E., 1997. Silver resistance mutants of Escherichia coli display active efflux Ag+ and are deficient in porins. J. Bacteriol. 19, 6127-6132
• Ovington L. G., 2004. The truth about silver. Ostomy Wound Manage. 50, 1-10.
• Percival S. L., Bowler P. G., Russel D., 2005. Bacterial resistance to silver in wound care. J. Hosp. Infect. 60, 1-7.
• Pike-Biegunski M. J., 2005. Nanotechnologia w medycynie i farmacji. Lek w Polsce 15, 30-37.
• Rosen B. P., 1996. Bacterial resistance to heavy metals and metalloids. J. Biol. Inorg. Chem. 1, 273-277.
• Russel A. D., Hugo W. B., 1994. Antimicrobial activity and action of silver. Prog. Med. Chem. 31, 351-370.
• Ruutu M., Alfthan O., Talja M., Andresson L. C., 1985. Cytotoxicity of latex urinary catheters. Br. J. Urol. 57, 82-87.
• Sagripanti J. L., 1992. Metal based formulation with high microbial activity. Apel. Environ. Microbiol. 58, 3157-3162.
• Samuel U., Guggenbichler J. P., 2004. Prevention of catheter-related infection: the potential of a new nano-silver impregnated catheter. Int. J. Antimicrob. Agents 23S1, 75-78.
• Schierholz J. M., Lucas L. J., Rump A., Pulverer G., 1998. Efficacy of silver-coated medical devices. J. Hosp. Infect. 40, 257-262.
• Silver S., 1996. Bacterial heavy metal resistance: new surprises. Ann. Rev. Microbiol. 50, 753-89.
• Silver S., 2003. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol. Rev. 27, 341-353.
• Słaba M., Długoński J., 2002. Mikrobiologiczne usuwanie i odzyskiwanie metali ciężkich. Post. Mikrobiol. 41, 167-183
• Taylor S. C., Weinberg J. M., 2003. Topical antimicrobial agent in dermatology. Clin. Dermatol. 21, 70-77.
• Wazait H. D., Patel H. R. H., Veer V., 2003. Catheter associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001). Br. J. Urol. 91, 806-809.